Literature DB >> 32608967

Nanopore and Nanoparticle Formation with Lipids Undergoing Polymorphic Phase Transitions.

Diana Cholakova1, Desislava Glushkova1, Slavka Tcholakova1, Nikolai Denkov1.   

Abstract

We describe several unexpected phenomena, caused by a solid-solid phase transition (gel-to-crystal) typical for all main classes of lipid substances: phospholipids, triglycerides, diglycerides, alkanes, etc. We discovered that this transition leads to spontaneous formation of a network of nanopores, spreading across the entire lipid structure. These nanopores are spontaneously impregnated (flooded) by water when appropriate surfactants are present, thus fracturing the lipid structure at a nanoscale. As a result, spontaneous disintegration of the lipid into nanoparticles or formation of double emulsions is observed, just by cooling and heating of an initial coarse lipid-in-water dispersion around the lipid melting temperature. The process of nanoparticle formation is effective even after incorporation of medical drugs of high load, up to 50% in the lipid phase. The role of the main governing factors is clarified, the procedure is optimized, and the possibility for its scaling-up to industrially relevant amounts is demonstrated.

Entities:  

Keywords:  nanoemulsion; nanopore; polymorphic phase transition; solid lipid nanoparticle; triacylglyceride; wetting

Mesh:

Substances:

Year:  2020        PMID: 32608967     DOI: 10.1021/acsnano.0c02946

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  2 in total

1.  Kinetic Study on Alpha-Form Crystallization of Mixed-Acid Triacylglycerols POP, PPO, and Their Mixture.

Authors:  Ken Taguchi; Akihiko Toda; Hironori Hondoh; Satoru Ueno; Kiyotaka Sato
Journal:  Molecules       Date:  2021-01-04       Impact factor: 4.411

2.  Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics.

Authors:  Anindita De; Young Tag Ko
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.